Cisco's orders up, but revenue declines

Cisco reported that while it saw year-over-year declines in both profits and revenues for its fiscal fourth quarter ending in June, the company also saw orders grow for the first time in the last four quarters.

The company reported that fourth-quarter revenues declined from €7.25 billion from the same period last year to €5.9  billion. Net income declined from €1.3 billion in fiscal Q4 2008 to €767million in fiscal Q4 2009.

One area of growth for Cisco was routing. Cisco's routing revenue was €1.3  billion, an 8% year-over-year increase. The company attributes overall growth of its router segment to 12% growth of its high-end router product portfolio.

The continued service provider deployment of its CRS-1 platform, which grew 85% year-over-year, was a major contributor to the growth in the router segment. Meanwhile, switching revenue was €2.4 billion, a 5% year-over-year increase.

Even with gains in its routing segment, the company continues to conduct cost-cutting measures. Late last month, Cisco announced that it would lay off an additional 700 employees.

Stopping short of saying that that the telecom market is rebounding, Cisco CEO John Chambers painted a positive, yet cautious, outlook for the company.

“We saw a number of positive signs this quarter in the economy and in our business, especially comparing our sequential quarter-over-quarter order trends,” he said in a press release.

“If we continue to see these positive order trends for the next one to two quarters, we believe there is a good chance we will look back and see that the tipping point occurred in our business in Q4.”

For more:
- see the earnings release here

[This article originally appeared in FierceTelecom]

Suggested Articles

Wireless operators can provide 5G services with spectrum bands both above and below 6 GHz—but that doesn't mean that all countries will let them.

Here are the stories we’re tracking today.

The 5G Mobile Network Architecture research project will implement two 5G use cases in real-world test beds.